TCL Archive FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer July 27, 2012
TCL Archive ACCC Seeks Greater Role In Clinical Research Priorities; Suggests Up To 400 Cancer Program April 13, 1979
TCL Archive NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement June 26, 1987